Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...
Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness.
Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower ...
FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...
Patients who switched from the brand-name antidepressant Wellbutrin XL 300 to generic bupropion saw panic attacks, headaches, nausea, dizziness, and more.
In a significant policy reversal, the National Institute for Health and Care Excellence (NICE) has recommended abiraterone ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...
HYDERABAD — Dr Reddy’s Laboratories is gearing up to enter the booming global obesity drug market with a more affordable generic version of Novo Nordisk’s leading weight-loss medication, Wegovy. The ...
The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help ...
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...
The Well News on MSN
FDA to Streamline Approvals for Less Expensive, Generic Biologic Drugs
WASHINGTON - The Food and Drug Administration announced Wednesday that it plans to streamline the approval process for ...
Key Points Added 4,306,363 Teva shares, an estimated $75.64 million trade based on the average quarterly price for Q3 2025 Transaction represents a 0.68% increase in reportable U.S. equity assets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback